drugset / Trial / NCT02256969
Intraductal Meibomian Gland Probing Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
In this research study, the investigators are looking at the effects of Meibomian Gland Probing (MGP) versus a sham (fake) procedure in patients with refractory MGD who have already tried traditional management with no success in resolving their clinical signs (as seen by their ophthalmologist) or their symptoms. The investigators are also evaluating the effects of using two (2) post-procedural medication treatments: Blephamide or GenTeal PM Night-Time to determine if treatment after the MGP procedure has an effect on its outcome.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenTeal PM Night-Time | Unknown | — | Topical |
| Comparator | Prednisolone | Other / unclassified | — | Topical |
| Comparator | Sulfacetamide | Small molecule | — | Topical |